High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina

Experimental Eye Research

Volumn 137, Issue , 2015, Pages 63-70

  Sakamoto, Kenji ^a   Mizuta, Aya ^a   Fujimura, Kyosuke ^a   Kurauchi, Yuki ^a   Mori, Asami ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

High mobility group Box 1; N methyl d aspartic acid; Oxidative stress; Retina; Toll like receptor

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR ANTAGONIST; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN Y; N METHYL DEXTRO ASPARTIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; N METHYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL LOSS; EXCITOTOXICITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NERVE CELL; NEUROTOXICITY; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA INJURY; SPRAGUE DAWLEY RAT; ANIMAL; APOPTOSIS; CHEMICALLY INDUCED; DISEASE MODEL; INJURIES; METABOLISM; PATHOLOGY; RETINA; RETINA DISEASE;

ANIMALS; APOPTOSIS; CELL DEATH; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; MALE; N-METHYLASPARTATE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RETINA; RETINAL DISEASES; RETINAL GANGLION CELLS;

EID: 84934959153     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.06.003     Document Type: Article

References (49)

1. Abeyama K., Stern D.M., Ito Y., Kawahara K., Yoshimoto Y., Tanaka M., Uchimura T., Ida N., Yamazaki Y., Yamada S., Yamamoto Y., Yamamoto H., Iino S., Taniguchi N., Maruyama I. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J.Clin. Invest. 2005, 115:1267-1274.
2. Anderson P.J., Watts H.R., Jen S., Gentleman S.M., Moncaster J.A., Walsh D.T., Jen L.S. Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons. Clin. Ophthalmol. 2009, 3:235-242.
3. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., Buss S., Autschbach F., Pleger S.T., Lukic I.K., Bea F., Hardt S.E., Humpert P.M., Bianchi M.E., Mairbäurl H., Nawroth P.P., Remppis A., Katus H.A., Bierhaus A. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117:3216-3226.
4. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J.Leukoc. Biol. 2007, 81:1-5.
5. Biscetti F., Straface G., De Cristofaro R., Lancellotti S., Rizzo P., Arena V., Stigliano E., Pecorini G., Egashira K., De Angelis G., Ghirlanda G., Flex A. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010, 59:1496-1505.
6. Calogero S., Grassi F., Aguzzi A., Voigtländer T., Ferrier P., Ferrari S., Bianchi M.E. The lack of chromosomal protein Hmgb1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999, 22:276-280.
7. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
8. Choi D.W. Ionic dependence of glutamate neurotoxicity in cortical cell culture. J.Neurosci. 1987, 7:369-379.
9. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988, 11:465-469.
10. David P., Lusky M., Teichberg V.I. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp. Eye Res. 1988, 46:657-662.
11. Davies M.H., Eubanks J.P., Powers M.R. Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol. Vis. 2006, 12:467-477.
12. Dvoriantchikova G., Barakat D.J., Hernandez E., Shestopalov V.I., Ivanov D. Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury. Mol. Vis. 2010, 16:2882-2890.
13. Dvoriantchikova G., Barakat D.J., Hernandez E., Shestopalov V.I., Ivanov D. Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury. Mol. Vis. 2010, 16:1907-1912.
14. Dvoriantchikova G., Hernandez E., Grant J., Santos A.R., Yang H., Ivanov D. The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest. Ophthalmol. Vis. Sci. 2011, 52:7187-7194.
15. Evankovich J., Cho S.W., Zhang R., Cardinal J., Dhupar R., Zhang L., Klune J.R., Zlotnicki J., Billiar T., Tsung A. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J.Biol. Chem. 2010, 285:39888-39897.
16. Faraco G., Fossati S., Bianchi M.E., Patrone M., Pedrazzi M., Sparatore B., Moroni F., Chiarugi A. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration invitro and invivo. J.Neurochem. 2007, 103:590-603.
17. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
18. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J.Neurosci. 2002, 22:RC216.
19. Fujita R., Ueda M., Fujiwara K., Ueda H. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell. Death Differ. 2009, 16:349-358.
20. Hangai M., Yoshimura N., Yoshida M., Yabuuchi K., Honda Y. Interleukin-1 gene expression in transient retinal ischemia in the rat. Invest. Ophthalmol. Vis. Sci. 1995, 36:571-578.
21. Hoppe G., Rayborn M.E., Sears J.E. Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation. J.Comp. Neurol. 2007, 501:219-230.
22. Kilic U., Kilic E., Matter C.M., Bassetti C.L., Hermann D.M. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol. Dis. 2008, 31:33-40.
23. Kuehn M.H., Fingert J.H., Kwon Y.H. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol. Clin. North Am. 2005, 18:383-395.
24. Langmann T. Microglia activation in retinal degeneration. J.Leukoc. Biol. 2007, 81:1345-1351.
25. Li J., Gong Q., Zhong S., Wang L., Guo H., Xiang Y., Ichim T.E., Wang C.Y., Chen S., Gong F., Chen G. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol. Dial. Transpl. 2011, 26:469-478.
26. Liu A., Jin H., Dirsch O., Deng M., Huang H., Bröcker-Preuss M., Dahmen U. Release of danger signals during ischemic storage of the liver: a potential marker of organ damage?. Mediat. Inflamm. 2010, 2010:436145.
27. Liu K., Mori S., Takahashi H.K., Tomono Y., Wake H., Kanke T., Sato Y., Hiraga N., Adachi N., Yoshino T., Nishibori M. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007, 21:3904-3916.
28. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
29. Louzada-Júnior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J.Neurochem. 1992, 59:358-363.
30. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J.Neurosci. 2008, 28:12023-12031.
31. Murphy M.P. Nitric oxide and cell death. Biochim. Biophys. Acta 1999, 1411:401-414.
32. Pedrazzi M., Raiteri L., Bonanno G., Patrone M., Ledda S., Passalacqua M., Milanese M., Melloni E., Raiteri M., Pontremoli S., Sparatore B. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J.Neurochem. 2006, 99:827-838.
33. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediat. Inflamm. 2010, 2010:672395.
34. Sakamoto K., Kawakami T., Shimada M., Yamaguchi A., Kuwagata M., Saito M., Nakahara T., Ishii K. Histological protection by cilnidipine, a dual L/N-type Ca2+ channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina. Exp. Eye Res. 2009, 88:974-982.
35. Sakamoto K., Hiraiwa M., Saito M., Nakahara T., Sato Y., Nagao T., Ishii K. Protective effect of all-trans retinoic acid on NMDA-induced neuronal cell death in rat retina. Eur. J. Pharmacol. 2010, 635:56-61.
36. Sakamoto K., Ohki K., Saito M., Nakahara T., Ishii K. Histological protection by donepezil against neurodegeneration induced by ischemia-reperfusion in the rat retina. J.Pharmacol. Sci. 2010, 112:327-335.
37. Sakamoto K., Ohki K., Saito M., Nakahara T., Ishii K. Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina. J.Ocul. Pharmacol. Ther. 2011, 27:419-425.
38. Sakamoto K., Suzuki Y., Kurauchi Y., Mori A., Nakahara T., Ishii K. Hydrogen sulfide attenuates NMDA-induced neuronal injury via its anti-oxidative activity in the rat retina. Exp. Eye Res. 2014, 120:90-96.
39. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
40. Seki M., Lipton S.A. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog. Brain Res. 2008, 173:495-510.
41. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
42. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1 and cancer. Biochim. Biophys. Acta 2010, 1799:131-140.
43. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 2008, 173:409-421.
44. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., Yang H., Li J., Tracey K.J., Geller D.A., Billiar T.R. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J.Exp. Med. 2005, 201:1135-1143.
45. Ubogu E.E., Cossoy M.B., Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006, 27:48-55.
46. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., Kobayashi A., Maruyama I., Yamada S., Hasegawa N., Soejima J., Koh H., Ishizaka A. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med. 2004, 170:1310-1316.
47. Wu H., Ma J., Wang P., Corpuz T.M., Panchapakesan U., Wyburn K.R., Chadban S.J. HMGB1 contributes to kidney ischemia reperfusion injury. J.Am. Soc. Nephrol. 2010, 21:1878-1890.
48. Yang H., Hirooka K., Liu Y., Fujita T., Fukuda K., Nakamutra T., Itano T., Zhang J., Nishibori M., Shiraga F. Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury. Curr. Eye Res. 2011, 36:1037-1046.
49. Yoneda S., Tanihara H., Kido N., Honda Y., Goto W., Hara H., Miyawaki N. Interleukin-1beta mediates ischemic injury in the rat retina. Exp. Eye Res. 2001, 73:661-667.